Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Brady Forcier"'
Autor:
Cathy Zhou, Zilong Yuan, Weijie Ma, Lihong Qi, Angelique Mahavongtrakul, Ying Li, Hong Li, Jay Gong, Reggie R. Fan, Jin Li, Michael Molmen, Travis A. Clark, Dean Pavlick, Garrett M. Frampton, Brady Forcier, Elizabeth H. Moore, David K. Shelton, Matthew Cooke, Siraj M. Ali, Vincent A. Miller, Jeffrey P. Gregg, Philip J. Stephens, Tianhong Li
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-13 (2018)
Abstract Background This retrospective study was undertaken to determine if the plasma circulating tumor DNA (ctDNA) level and tumor biological features in patients with advanced solid tumors affected the detection of genomic alterations (GAs) by a p
Externí odkaz:
https://doaj.org/article/f7a6b3e50e784343a7af265214bc7dc3
Autor:
Vincent A. Miller, Siraj M. Ali, Fadi Braiteh, Craig Devoe, Philip J. Stephens, Jeffrey S. Ross, Jason K. Sicklick, Razelle Kurzrock, Joseph Chao, Richard D. Carvajal, Rodolfo Bordoni, Bryan Leyland-Jones, Lauren Young, Allison Welsh, Brady Forcier, Jon H. Chung, Samuel J. Klempner, Dean Pavlick, Alexa B. Schrock
Supplemental Figure 1. Distribution of EGFR extracellular domain (ECD) mutations in ctDNA samples from patients with CRC. Supplemental Figure 2. Response to crizotinib in a patient with small bowel adenocarcinoma and GOPC-ROS1 fusion. Supplemental Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170255c4ff650fe8b42505905ee89975
https://doi.org/10.1158/1078-0432.22470560.v1
https://doi.org/10.1158/1078-0432.22470560.v1
Autor:
Vincent A. Miller, Siraj M. Ali, Fadi Braiteh, Craig Devoe, Philip J. Stephens, Jeffrey S. Ross, Jason K. Sicklick, Razelle Kurzrock, Joseph Chao, Richard D. Carvajal, Rodolfo Bordoni, Bryan Leyland-Jones, Lauren Young, Allison Welsh, Brady Forcier, Jon H. Chung, Samuel J. Klempner, Dean Pavlick, Alexa B. Schrock
Purpose: Genomic profiling of tumor biopsies from advanced gastrointestinal and anal cancers is increasingly used to inform treatment. In some cases, tissue biopsy can be prohibitive, and we sought to investigate whether analysis of blood-derived cir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f585f9528efe486d07e5f1a6116054
https://doi.org/10.1158/1078-0432.c.6527618.v1
https://doi.org/10.1158/1078-0432.c.6527618.v1
Autor:
Brady Forcier, Alexa B. Schrock, Siraj M. Ali, Jon Chung, Allison Welsh, Jeffrey S. Ross, Philip J. Stephens, Dean Pavlick, Vincent A. Miller, Alice T. Shaw, Eric H. Bernicker, Sai-Hong Ignatius Ou, Tianhong Li, Benjamin C. Creelan, Ibiayi Dagogo-Jack
Publikováno v:
Journal of Thoracic Oncology. 14:255-264
Introduction Genomic profiling informs selection of matched targeted therapies as part of routine clinical care in NSCLC. Tissue biopsy is the criterion standard; however, genomic profiling of blood-derived circulating tumor DNA (ctDNA) has emerged a
Autor:
Lauren Young, Samuel J. Klempner, Jeffrey S. Ross, Bryan Leyland-Jones, Fadi Braiteh, Razelle Kurzrock, Siraj M. Ali, Brady Forcier, Alexa B. Schrock, Vincent A. Miller, Jason K. Sicklick, Allison Welsh, Craig Devoe, Rodolfo Bordoni, Dean Pavlick, Richard D. Carvajal, Jon Chung, Joseph Chao, Philip J. Stephens
Publikováno v:
Clinical Cancer Research. 24:1881-1890
Purpose: Genomic profiling of tumor biopsies from advanced gastrointestinal and anal cancers is increasingly used to inform treatment. In some cases, tissue biopsy can be prohibitive, and we sought to investigate whether analysis of blood-derived cir
Autor:
Jeffrey S. Ross, A. D. Hoffman, Joyce O'Shaughnessy, Tariq I Mughal, Linda T. Vahdat, Ping Ye, Jon Chung, Brian Leyland-Jones, Shridar Ganesan, Michael E. Goldberg, Doron Lipson, G.M. Frampton, V.A. Miller, Alexa B. Schrock, Phillip J. Stephens, Maren K. Levin, Siraj M. Ali, Lauren Young, D. M. Nguyen, Ryan J. Hartmaier, Ben Ho Park, H. A. Burris, Dean Pavlick, Brady Forcier, Lajos Pusztai
Publikováno v:
Annals of Oncology
Background Genomic changes that occur in breast cancer during the course of disease have been informed by sequencing of primary and metastatic tumor tissue. For patients with relapsed and metastatic disease, evolution of the breast cancer genome high
Autor:
Bradford A. Tan, Patrick Ward, Jeff Edenfield, Alexa B. Schrock, Dean Pavlick, Jeffrey P. Gregg, Gerald Li, Brady Forcier, Ahad Sadiq, Julio Peguero, Todd M. Bauer, Andre Kallab, Michelle Nahas, Siraj M. Ali, Matthew Cooke, Jeffrey S. Ross, Jie He, Jason D. Hughes, Anthony Hoffman, Jon Chung, Phil Stephens, Jose A. Bufill, Vincent A. Miller
Publikováno v:
Journal of gastrointestinal oncology. 10(5)
Background: Liquid biopsy offers the ability to non-invasively analyze the genome of a tumor through circulating tumor DNA (ctDNA) to identify targetable and prognostic genomic alterations. Few studies have rigorously analyzed ctDNA results and deter
Autor:
Travis A. Clark, Weijie Ma, Jay Gong, Zilong Yuan, David K. Shelton, Dean Pavlick, Brady Forcier, Elizabeth H Moore, Hong Li, Matthew Cooke, Vincent A. Miller, Michael Molmen, Reggie R. Fan, Garrett M. Frampton, Siraj M. Ali, Ying Li, Angelique Mahavongtrakul, Cathy Zhou, Jin Li, Tianhong Li, Lihong Qi, Jeffrey P. Gregg, Philip J. Stephens
Publikováno v:
Journal of hematology & oncology, vol 11, iss 1
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-13 (2018)
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-13 (2018)
Journal of Hematology & Oncology
Background This retrospective study was undertaken to determine if the plasma circulating tumor DNA (ctDNA) level and tumor biological features in patients with advanced solid tumors affected the detection of genomic alterations (GAs) by a plasma ctD
Autor:
T. Regalo, Brady Forcier, Dean Pavlick, Weijie Ma, S. Chen, B. Sawchyn, Jeffrey P. Gregg, Tianhong Li, Michael Molmen, Y. Yan
Publikováno v:
Journal of Thoracic Oncology. 14:S586-S587
Autor:
Adam Hyman, Jennifer Saggio, Kristopher R. Bosse, John Wick, Brady Forcier, Anne Marie Murphy, Matthew Cooke, Maria Lane, Siraj M. Ali, John M. Maris, Russell Madison, Samantha Buongervino, Jennifer Webster, Alana Fitzsimmons, Yael P. Mosse, Alley Welsh, Maria Gemino-borromeo, Vincent A. Miller
Publikováno v:
Cancer Research. 79:3105-3105
Background: Analysis of circulating tumor DNA (ctDNA) provides a noninvasive method to profile tumor-associated genomic aberrations, heterogeneity and evolution. Methods: Peripheral blood from 5 newly diagnosed and 33 relapsed high-risk neuroblastoma